Moses Rodriguez, MD

Affiliations: 
Neurology Mayo Clinic, Rochester, MN, United States 
Google:
"Moses Rodriguez"
Bio:

MAYO CLINIC
NEUROLOGY DEPT W8A
200 1ST ST SW
ROCHESTER, MN 559050002
United States

Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Watzlawik JO, Kahoud RJ, Wootla B, et al. (2016) Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study. Journal of Visualized Experiments : Jove
Mangalam AK, Rattan R, Suhail H, et al. (2016) AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis. Journal of Immunology (Baltimore, Md. : 1950)
Chen J, Chia N, Kalari KR, et al. (2016) Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Scientific Reports. 6: 28484
McDonald J, Graves J, Waldman A, et al. (2016) A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Multiple Sclerosis and Related Disorders. 6: 87-92
Wootla B, Watzlawik JO, Stavropoulos N, et al. (2016) Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis. Expert Opinion On Biological Therapy
Painter MM, Morrison JH, Zoecklein LJ, et al. (2015) Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity. Plos Pathogens. 11: e1005311
Poisson LM, Suhail H, Singh J, et al. (2015) Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis. The Journal of Biological Chemistry
Wootla B, Denic A, Watzlawik JO, et al. (2015) Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease. Molecular Neurobiology
Wootla B, Watzlawik JO, Warrington AE, et al. (2015) Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases. Jama Neurology
Novotna M, Paz Soldán MM, Abou Zeid N, et al. (2015) Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis. Neurology. 85: 722-9
See more...